NEUP vs ROK · rev $15.7M vs P/E 48, rev $8.34B
Neuphoria Therapeutics Inc (NEUP) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
NEUP currently screens at market cap $23.6M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the NEUP and ROK stock pages for the full models.
Not investment advice.